Literature DB >> 23958547

Expression of REG4 in ovarian mucinous tumors.

Qiong Huang1, Xiaoduan Chen, Weiguo Lu, Maode Lai, Bingjian Lu.   

Abstract

Regenerating islet-deprived gene family, number 4 (REG4), is a novel marker for intestinal differentiation. We performed immunohistochemical studies on REG4, cytokeratin (CK)7, CK20, and caudal type homeobox 2 (CDX2) in 291 ovarian mucinous tumors. There were 226 primary tumors and 65 metastatic tumors. The primary tumors comprised 69/226 mucinous cystadenomas, 79/226 mucinous borderline tumors (64/79 intestinal-type and 15/79 endocervical-like tumors), and 78/226 mucinous carcinomas. We found that REG4 expression was significantly higher in mucinous borderline tumors (30/79, 38.0%) and primary mucinous carcinomas (26/78, 33.3%) than in mucinous cystadenomas (4/69, 5.8%; P<0.05). However, REG4 expression was more commonly associated with intestinal-type, borderline, mucinous tumors rather than the endocervical-like type (30/64 vs. 0/15, P<0.001). There was a significant correlation between the REG4 and CDX2 expression profiles in primary ovarian mucinous tumors (r=0.772, P<0.001). REG4, CDX2, and diffuse CK20 had higher expression frequencies in metastatic lower gastrointestinal adenocarcinoma than in primary mucinous tumors (P<0.01). The CK7/REG4 coordinate expression profile was comparable in diagnostic value to CK7/CK20 or CK7/CDX2 profile. We conclude that REG4 expression is common in mucinous borderline tumors of the intestinal type as it is absent in the endocervical-like form in this series. Expression of CK7/REG4 may contribute to the differential diagnosis between primary and metastatic ovarian mucinous tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23958547     DOI: 10.1097/PAI.0b013e3182936d8e

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  4 in total

1.  The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.

Authors:  Shuo Chen; Wen-Feng Gou; Shuang Zhao; Zhe-Feng Niu; Yang Zhao; Yasuo Takano; Hua-Chuan Zheng
Journal:  BMC Cancer       Date:  2015-06-16       Impact factor: 4.430

Review 2.  The Clinical Significance and Mechanisms of REG4 in Human Cancers.

Authors:  Junyan Zhang; Zhi Zhu; Zhifeng Miao; Xuanzhang Huang; Zhe Sun; Huimian Xu; Zhenning Wang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

3.  Upregulation of REG IV gene in human intestinal epithelial cells by lipopolysaccharide via downregulation of microRNA-24.

Authors:  Shin Takasawa; Chikatsugu Tsuchida; Sumiyo Sakuramoto-Tsuchida; Tomoko Uchiyama; Mai Makino; Akiyo Yamauchi; Asako Itaya-Hironaka
Journal:  J Cell Mol Med       Date:  2022-08-09       Impact factor: 5.295

Review 4.  REG4 promotes the proliferation and anti-apoptosis of cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Cell Dev Biol       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.